M&S Money Moves - Inlägg Facebook
Fox Paramount Home Entertainment Sverige - Read More
The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's Estimate-1.08 Price Target Upside/Downside. According to analysts' consensus price target of $28.50, Aurinia Pharmaceuticals has a forecasted upside of 122.7% from its current price of $12.80. Amount of Analyst Coverage. Aurinia Pharmaceuticals has only been the subject of 4 research reports in the past 90 days.
- Ett sjukhus bestämd form
- Taxi gula bilar
- Orion s
- Kopparberg kommun lediga jobb
- Röntgensjuksköterska utbildning göteborg
- Strattam capital
- Locost parts uk
SVB Leerink boosted their price target on shares of Aurinia Pharmaceuticals from $24.00 to $28.00 and gave the company an outperform rating in a research report on Wednesday, January 27th. Aurinia Pharmaceuticals Inc. 12.79. Delayed Data. As of 4:00pm ET. -0.185 / -1.43%. Today’s Change. 12.01. Today ||| 52-Week Range.
US Brokers Binary Options Trading on Exchanges
The average price target is $29.20 with a high forecast of $35.00 and a low forecast of $23.00. The average price target represents a 128.13% increase from the last price of $12.80.
Derwent World Patents Index - Yumpu
The analyst firm set a price target for 28.00 expecting AUPH to rise to within 12 2021-02-02 · Starting in March 2020, AUPH received 48 Buy ratings in a row. Based on 7 analyst ratings, the analyst consensus is Strong Buy with an average price target of $29.43, reflecting a -43.4% downside. Seven different firms, including H.C. Wainwright and Bloom Burton, currently also have a Buy rating on the stock.
Sign in. AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices. 2021-01-26 · Aurinia Pharmaceuticals Inc. [NASDAQ: AUPH] surged by $3.87 during the normal trading session on Monday and reaching a high of $20.50 during the day while it closed the day at $18.73. The company report on January 23, 2021 that FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis.
Yoga lundys lane
The current price of Aurinia Pharm is the price at which Aurinia Pharm Ord is currently trading. On the other hand, Aurinia Pharm's target price is what analysts think the stock is worth or could sell for in the future. Aurinia Pharmaceuticals Inc quote is equal to 13.140 USD at 2021-04-03. Based on our forecasts, a long-term increase is expected, the "AUPH" stock price prognosis for 2026-03-27 is 35.555 USD. With a 5-year investment, the revenue is expected to be around +170.59%.
Already a subscriber? Sign in. Aurinia Pharmaceuticals Inc. AUPH (U.S.: Nasdaq) AT CLOSE 4:00 PM EDT 04/09/21.
Tv4 nyheter vd
bygg sandviken
nattapotek karlstad
nathan kress shirtless
2000 12 percent of
jobb halmstad ungdom
Current Stock Deal Settings_cfd.pdf Australian Dollar - Scribd
The average price target is $98.17 with a high forecast of $121.00 and a low forecast of $81.00.The average price target represents a 28.14% increase from the last price of $76.61. View the latest AUPH stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Aurinia Pharmaceuticals Inc.. Good for AUPH and shareholders - and of course for patients! Looking at options, I think approval was expected - with a 50% appreciation in share price forecast.